Literature DB >> 12437384

Influence of DNA structures on the conversion of sanguinarine alkanolamine form to iminium form.

Motilal Maiti1, Suman Das, Anjana Sen, Arunangshu Das, Gopinatha Suresh Kumar, Ruma Nandi.   

Abstract

Sanguinarine exhibits pH dependent structural equilibrium between iminium form (structure I) and alkanolamine form (structure II) with a pKa of 7.4 as revealed from spectrophotometric titration. The titration data show that the compound exists almost exclusively as structure I and structure II in the pH range 1 to 6 and 8.5 to 11, respectively. The interaction of structure I and structure II to several B-form natural and synthetic double and single stranded DNAs has been studied by spectrophotometric, spectrofluorimetric and circular dichroic measurements in buffers of pH 5.2 and pH 10.4 where the physicochemical properties of DNA remain in B-form structure. The results show that structure I bind strongly to all B-form DNA structures showing typical hypochromism and bathochromism of the alkaloid's absorption maximum, quenching of steady-state fluorescence intensity and perturbations in circular dichroic spectrum. The structure II does not bind to DNA, but in presence of large amount of DNA significant population of structure I is generated, which binds to DNA and forms a structure I-DNA intercalated complex. The nature and magnitude of the spectral pattern are very much dependent on the structure as well as base composition of each DNA. The generation of the structure I from structure II is significantly affected by increasing ionic strength of the medium. The conversion of structure II to structure I in presence of high concentration of DNA in solution is explained through formation of a binding equilibrium process between structure II and structure I-DNA intercalated complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12437384     DOI: 10.1080/07391102.2002.10506864

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  9 in total

Review 1.  Natural isoquinoline alkaloids: binding aspects to functional proteins, serum albumins, hemoglobin, and lysozyme.

Authors:  Asma Yasmeen Khan; Gopinatha Suresh Kumar
Journal:  Biophys Rev       Date:  2015-11-16

Review 2.  Biophysical aspects and biological implications of the interaction of benzophenanthridine alkaloids with DNA.

Authors:  Motilal Maiti; Gopinatha Suresh Kumar
Journal:  Biophys Rev       Date:  2009-08-25

3.  Fluorescence properties of selected benzo[c]phenanthridines.

Authors:  Kamil Motyka; Jakub Stýskala; Petr Cankař; Jan Hlaváč
Journal:  J Fluoresc       Date:  2014-05-06       Impact factor: 2.217

4.  Polymorphic nucleic Acid binding of bioactive isoquinoline alkaloids and their role in cancer.

Authors:  Motilal Maiti; Gopinatha Suresh Kumar
Journal:  J Nucleic Acids       Date:  2009-12-15

5.  Interaction of the anticancer plant alkaloid sanguinarine with bovine serum albumin.

Authors:  Maidul Hossain; Asma Yasmeen Khan; Gopinatha Suresh Kumar
Journal:  PLoS One       Date:  2011-04-06       Impact factor: 3.240

6.  Cytotoxic, genotoxic, and oxidative stress-related effects of lysergic acid diethylamide (LSD) and phencyclidine (PCP) in the human neuroblastoma SH-SY5Y cell line.

Authors:  Andreja Jurič; Antonio Zandona; Blanka Tariba Lovaković; Dubravka Rašić; Alica Pizent; Goran Kozina; Maja Katalinić; Ana Lucić Vrdoljak; Irena Brčić Karačonji
Journal:  Arh Hig Rada Toksikol       Date:  2021-12-30       Impact factor: 1.948

7.  DNA abasic site-selective enhancement of sanguinarine fluorescence with a large emission shift.

Authors:  Fei Wu; Yanwei Sun; Yong Shao; Shujuan Xu; Guiying Liu; Jian Peng; Lingling Liu
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

Review 8.  Sanguinaria canadensis: Traditional Medicine, Phytochemical Composition, Biological Activities and Current Uses.

Authors:  Andrew Croaker; Graham J King; John H Pyne; Shailendra Anoopkumar-Dukie; Lei Liu
Journal:  Int J Mol Sci       Date:  2016-08-27       Impact factor: 5.923

Review 9.  Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19.

Authors:  Mehdi Valipour; Afshin Zarghi; Mohammad Ali Ebrahimzadeh; Hamid Irannejad
Journal:  Cell Cycle       Date:  2021-09-29       Impact factor: 4.534

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.